http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105753963-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
| filingDate | 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105753963-B |
| titleOfInvention | High activity Exenatide analog and its medical applications |
| abstract | The invention discloses a kind of Exenatide (Exendin-4) analogs.The activity of such analog stimulation rat Islet cells oncocyte INS-1 excreting insulin is apparently higher than wild type Exenatide, and hypoglycemic activity is also significantly better than wild type Exenatide in diabetic mice C57BL/KsJ-db/db body, can be used for preventing, treating or mitigating diabetes and obesity and the other diseases by reducing blood glucose, inhibiting gastrointestinal motility, gastric emptying benefited. |
| priorityDate | 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 361.